Veracyte (VCYT) Stock: Buy, Sell, or Hold?
VCYT - Veracyte, Inc.
$40.87
-1.16 (-2.76%)
âŧ
5d:
-8.51%
30d:
-8.53%
90d:
-13.81%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 03, 2026
Get Alerted When VCYT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: VCYT is fairly priced but lacks strong directional signals. At -3.4% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: VCYT is fairly priced but lacks strong directional signals. At -3.4% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$54.46
Based on 3.1% avg growth
INTRINSIC VALUE TODAY
$33.82
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 24.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VCYT is currently trading at $40.87, which is considered fair relative to its 30-day fair value range of $42.07 to $45.67. From a valuation perspective, the stock is trading at a discount (Forward PE: 21.6) compared to its historical average (24.0). Remarkably, the market is currently pricing in an annual earnings decline of 3.4% over the next few years. This pessimistic expectation contrasts with the company's recent 288.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, VCYT is showing support break momentum. The price is currently testing key support at $40.79. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: VCYT scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $57.82 (+37.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VCYT is showing support break momentum. The price is currently testing key support at $40.79. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: VCYT scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $57.82 (+37.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$42.07 -
$45.67
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
50.0%
Protect Your Profits
Holding VCYT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (38/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 37.6% below Wall St target ($57.82)
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$42.07 -
$45.67
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$40.79
Resistance Level
$45.99
Current Trend
Support Break
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
21.57
Wall Street Target
$57.82
(+37.6%)
Revenue Growth (YoY)
15.5%
Earnings Growth (YoY)
288.9%
Profit Margin
20.4%
Valuation Discount vs History
-3.4% cheaper
PE vs Historical
21.6 vs 24.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.4%
(market-implied from PE analysis)
1-Year Target
$40.60
(-3%)
2-Year Target
$39.22
(-7%)
3-Year Target
$37.89
(-10%)
3-Yr Target (if PE normalizes)
(PE: 22â24)
$42.15
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.6, Growth: 2.2%)
$44.86
(+7%)
Base:
(SPY PE: 20.2, Growth: 2.2%)
$41.94
(0%)
Bear:
(PE: 17.1, Growth: 2.2%)
$35.65
(-15%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (31x PE), but valuation improves significantly next year (22x PE) as earnings recover.
Trailing PE: 31.33 | Current EPS (TTM): $1.40
Bull Case
$67.14
(+60%)
Analyst growth 39.2%, PE expands to 34.5
Base Case
$61.03
(+45%)
Market implied 39.2%, PE stable at 31.3
Bear Case
$29.82
(-29%)
Severe decline -20.0%, PE contracts to 26.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 21.6 to 24.0
Stabilization Target:
$46.76
(+11.2%)
PE Expansion Potential:
+11.2%
Share & Embed Analysis
Last updated: September 11, 2026 4:21 PM ET
Data refreshes hourly during market hours. Next update: 5:21 PM
Data refreshes hourly during market hours. Next update: 5:21 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VCYT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher ScientificâĻ |
STRONG BUY
31 analysts |
$638 | 51 HOLD |
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$229 | 49 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 49 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$338 | 47 HOLD |
Advanced VCYT Option Strategies
Professional options setups generated by AI based on today's VCYT price and gamma walls.
